Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012-Reference-Cited by-同舟云学术

Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012

Published:2015-11-04 Issue:11 Volume:10 Page:e0140881
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Miramontes Roque,Hill Andrew N.,Yelk Woodruff Rachel S.,Lambert Lauren A.,Navin Thomas R.,Castro Kenneth G.,LoBue Philip A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Global tuberculosis report 2014,2014

2. Trends in tuberculosis—United States, 2013;NN Alami;MMWR Morb Mortal Wkly Rep,2014

3. Prospects for tuberculosis elimination;C Dye;Annu Rev Public Health,2013

4. Stopping tuberculosis in the 21st century: goals and strategies;I Onozaki;Respirology,2010

5. World Health Organization. Report of the 13th Meeting WHO Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) 11–12 June 2013. Document WHO/HTM/TB/2013.09. Geneva, World health Organization. 2013.

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Process and Outcome Evaluation of the Centers for Disease Control and Prevention’s Think. Test. Treat TB Health Communications Campaign, United States, March–September 2022;Public Health Reports®;2024-08-27

2. Diagnostic Utility of QuantiFERON-Gold Testing in Patients with Ocular Inflammation in a Low-Endemic Tuberculosis Region;American Journal of Ophthalmology;2024-08

3. The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study;The Lancet Public Health;2024-08

4. Overlooked, dismissed, and downplayed: reversion ofMycobacterium tuberculosisimmunoreactivity;European Respiratory Review;2024-07

5. Factors Associated With the Discontinuation of Two Short-Course Tuberculosis Preventive Therapies in Programmatic Settings in the United States;Open Forum Infectious Diseases;2024-06